全文获取类型
收费全文 | 85859篇 |
免费 | 6852篇 |
国内免费 | 4010篇 |
专业分类
耳鼻咽喉 | 302篇 |
儿科学 | 1569篇 |
妇产科学 | 1047篇 |
基础医学 | 14731篇 |
口腔科学 | 1061篇 |
临床医学 | 6497篇 |
内科学 | 18983篇 |
皮肤病学 | 1282篇 |
神经病学 | 3420篇 |
特种医学 | 1735篇 |
外国民族医学 | 22篇 |
外科学 | 4870篇 |
综合类 | 13362篇 |
现状与发展 | 21篇 |
预防医学 | 6698篇 |
眼科学 | 917篇 |
药学 | 10843篇 |
27篇 | |
中国医学 | 4181篇 |
肿瘤学 | 5153篇 |
出版年
2024年 | 147篇 |
2023年 | 961篇 |
2022年 | 2213篇 |
2021年 | 2777篇 |
2020年 | 2604篇 |
2019年 | 2742篇 |
2018年 | 2615篇 |
2017年 | 2709篇 |
2016年 | 3087篇 |
2015年 | 3399篇 |
2014年 | 5602篇 |
2013年 | 5956篇 |
2012年 | 5950篇 |
2011年 | 6299篇 |
2010年 | 5076篇 |
2009年 | 4854篇 |
2008年 | 4758篇 |
2007年 | 4477篇 |
2006年 | 4041篇 |
2005年 | 3506篇 |
2004年 | 2941篇 |
2003年 | 2520篇 |
2002年 | 2074篇 |
2001年 | 1809篇 |
2000年 | 1402篇 |
1999年 | 1242篇 |
1998年 | 1142篇 |
1997年 | 940篇 |
1996年 | 809篇 |
1995年 | 796篇 |
1994年 | 658篇 |
1993年 | 575篇 |
1992年 | 515篇 |
1991年 | 406篇 |
1990年 | 363篇 |
1989年 | 329篇 |
1988年 | 270篇 |
1987年 | 238篇 |
1986年 | 202篇 |
1985年 | 485篇 |
1984年 | 507篇 |
1983年 | 404篇 |
1982年 | 410篇 |
1981年 | 340篇 |
1980年 | 315篇 |
1979年 | 282篇 |
1978年 | 212篇 |
1977年 | 169篇 |
1976年 | 184篇 |
1975年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Eran Maman David M. Steinberg Batia Stark Shai Izraeli Shlomo Wientroub 《Journal of children's orthopaedics》2007,1(1):63-68
Purpose Studies on musculoskeletal manifestations (MSM) of childhood acute lymphoblastic leukemia (ALL) have yielded variable findings
with regard to their clinical impact. We investigated the significance for differential diagnosis, treatment and outcome of
musculoskeletal complaints as presenting symptoms of ALL, and their correlation with leukemia immunophenotypes, for which
data is lacking.
Methods Data on 783 children in the national study for childhood ALL between 1984 and 2003 were reviewed retrospectively. Statistical
analysis examined possible relationships between MSM at the time of diagnosis and demographic and clinical data, biological
features of leukemia (peripheral blood counts, immunophenotype and main cytogenetic aberration), response to initial prednisone
treatment, and outcome.
Results Of 765 children with data on orthopaedic complaints, 240 presented with MSM (31.4%). Among these children, B cell precursor
(BCP) was much more common (209/576, 36.3%) than T cell ALL (25/176, 14.2%). Patients with MSM had lower white blood cell
counts (WBC) (median of 9 vs. 20 × 109/L, P < 0.001) and percentage of blast cells in the peripheral blood at diagnosis compared to those without (median of 27 vs. 53%,
P < 0.001). Hepatomegaly and splenomegaly were less common in MSM group (67 vs. 53% <3 cm, P < 0.001, and 63 vs. 50% <3 cm, P < 0.001, respectively). Poor response to initial treatment with prednisone was recorded in 7.1% of patients with MSM versus
11.5% of those without (P = 0.086). The analysis revealed no independent effect of MSM on event-free survival (EFS), after correcting for differences
in EFS related to immunophenotype or initial WBC.
Conclusions MSM occur mostly in children with BCP ALL who present with less involvement of extramedullary organs, low peripheral blood
blasts and white blood cells counts. These findings highlight the importance of including ALL in the differential diagnosis
of MSM even in the presence of an apparently normal peripheral blood count. Our study also suggests that MSM are caused by
leukemic cells with enhanced biological propensity to remain relatively confined within the intramedullary bone-marrow space. 相似文献
92.
A. L. Snow M. Vaysberg S. M. Krams O. M. Martinez 《American journal of transplantation》2006,6(5P1):976-985
Lymphomas associated with post-transplant lymphoproliferative disease (PTLD) represent a significant complication of immunosuppression in transplant recipients. In immunocompetent individuals, EBV-specific cytotoxic T lymphocytes (CTL) prevent the outgrowth of activated B lymphoblasts through apoptosis induction. Soluble versions of TNF-related apoptosis-inducing ligand/Apo2 ligand (TRAIL) can induce apoptosis in numerous tumor cell types. Given the therapeutic potential of TRAIL, we examined the sensitivity of EBV+ spontaneous lymphoblastoid cell lines (SLCL) derived from patients with PTLD to treatment with soluble TRAIL. Despite abundant expression of TRAIL receptors (TRAIL-R), resistance to TRAIL-induced apoptosis was observed in all SLCL examined. This resistance could not be overcome by concomitant treatment with several pharmacological agents. Unlike BJAB positive control cells, for each SLCL tested, cleavage and activation of caspase 8 was inhibited due to failed recruitment of FADD and caspase 8 to TRAIL receptors upon stimulation. Further indicative of a proximal defect, TRAIL receptor aggregation could not be detected on the cell surface of SLCL following ligand engagement. These results suggest that the use of TRAIL for eliminating PTLD-associated tumors may be of limited clinical utility, and illustrate another mechanism by which EBV+ B lymphoma cells can evade tumor surveillance at the level of death receptor signaling. 相似文献
93.
目的 大量富集三裂叶蟛蜞菊倍半萜内酯A,B(WTA,WTB)。方法 采用气相色谱法测定WTA和WTB,并以WTA和WTB的含量、洗脱率、精制度为考察指标,研究D101大孔树脂吸附WTA和WTB的工艺条件及参数。结果 通过大孔树脂吸附后,WTA和WTB的洗脱率达90%,50%乙醇洗脱部分中WTA和WTB的含量为总固物的4.01%~4.09%。结论 可以采用大孔树脂富集WTA和WTB。 相似文献
94.
江门市区实施乙型肝炎免疫策略16年的效果评价 总被引:6,自引:5,他引:1
目的:对江门市区1986年1月1日起全面实施的乙型肝炎(乙肝)免疫策略进行效果评价。方法:运用血清流行病学调查和疫情资料对比分析,比较实施“免疫策略”前后江门市区0~15岁人群乙肝发病率和感染率变化情况和乙肝表面抗体(抗-HBs)增长情况。结果:实施“免疫策略”后16年,0~15人群的乙肝发病率由1985年的367.39/10万,降至2001年的21.10/10万,下降94.26%;HBsAg阳性率由1985年的9.17%降至2002年的0.6%,下降93.46%;乙肝病毒总感染率由1985年的35.82%降至2002年的1.20%,下降96.65%;抗-HBs阳性率由1985年的24.64%上升到2002年的93.00%,上升2.77倍。结论:江门市区现行乙肝免疫策略效果显,能有效预防和控制地区性大面积的乙肝流行与传播。经过一代人的努力,能彻底改变人口乙肝高发病率和HBV高感染率及高携带率的状况。 相似文献
95.
不同营养支持方式对肠外瘘患者人体组成改善作用之比较 总被引:1,自引:1,他引:0
目的观察不同营养支持方式对肠外瘘患者人体组成的改善作用。方法30例肠外瘘患者分成两组各15例,分别给予全肠外营养支持(TPN)或全肠内营养支持(TEN),观察10d前后患者人体组成及血清胰岛素样生长因子-1(IGF-1)的变化。结果10d后所有患者的体重指数(BMI)与体细胞群(BCM)显著改善,而TEN组患者10d前后BCM增加幅度更明显,分别为(27.5±0.8)kg和(29.0±0.6)kg,Day10与Day0相比,P<0.01。两组患者总体水(TBW)与细胞内水(ICW)均增加,尤其ICW,Day10与Day0相比,TEN组P<0.01;TPN组P<0.05。血清IGF-1在两组患者治疗后均有显著上升,TEN组增加幅度更明显,Day0为(175.0±32.9)ng/ml,Day10为(255.5±34.1)ng/ml,与Day0比较,P<0.01;与TPN组比较,P<0.05。IGF-1的变化与BCM的改善显著正相关(r2=0.16,P<0.05)。结论营养支持治疗能显著改善肠外瘘患者的体细胞群,纠正细胞内、外水的异常分布,而EN作用更明显。 相似文献
96.
一些损伤和疾病平时罕见,特殊情况下可以发生,造成严重危害。特殊情况主要包括严重事故、灾害、战争、恐怖主义活动以及特殊环境与特殊作业的危害等。本阐述了现代战争中发生的贫铀武器伤害、燃料空气炸弹伤害、微波武器伤害和战时精神疾病;可能源于恐怖主义活动的炭疽、天花;严重事故性伤害中的核事故、化学事故和煤矿事故伤害;严重灾害中的地震、海难(海战)落海伤害。中介绍了这些伤病的发生情况、伤害特点与医学救治。 相似文献
97.
The pathomechanisms involved in the neuronal dysfunction in Huntington disease (HD) are still unresolved and may be heterogeneous. One potential mechanism might be related to the induction of mitochondrial dysfunction in the CNS. This might lead firstly to neuronal dysfunction and finally to the activation of apoptotic pathways. Several compounds, which should alleviate mitochondrial dysfunction, have been tested in preclinical models as well as in clinical trials of different scale. Recently we reported the efficacy of Ethyl-eicosapentaenoic acid (Ethyl-EPA) in patients with HD. Ethyl-EPA is a polyunsaturated fatty acid from the n − 3 group, which is in clinical development for HD and melancholic depression. In our trial with Ethyl-EPA in HD responding patients could be characterized by either a lower CAG repeat number or a chorea-predominant clinical expression of the disease. Here we would like to describe some evidence on the potential mechanism of action of Ethyl-EPA in HD. We specifically focus on pathways, which are known to be influenced in HD and are modified by Ethyl-EPA and which points to an involvement of mitochondrial function as a common target. Some attention is given to the NF-kappa B pathway and the c-Jun amino-terminal kinases (JNK) pathway, which both may lead to an activation of the antiproliferative factor p53 and consequently mitochondrial dysfunction. Further the effects of EPA or Ethyl-EPA in preclinical models of HD are described. The evidence from these studies led to the design of phase III clinical trials, which are ongoing. 相似文献
98.
目的 研究在IL 2和IL 4作用下 ,趋化性细胞因子受体CCR3在人生发中心 (germinalcenter,GC)B细胞上的表达及其功能特性。方法 采用流式细胞术检测人GCB细胞上CCR3表达和在CCR3配体eotaxin作用下B细胞的凋亡 ,实时定量RT PCR和Northernblot法检测GCB细胞内CCR3mRNA的表达 ,淋巴细胞趋化和黏附试验检测B细胞的趋化和黏附能力。结果 人GCB细胞极低表达趋化性细胞因子受体CCR3,经IL 2和IL 4作用后 ,GCB细胞高表达CCR3,但此时CCR3不能在其配体作用下诱导GCB细胞的趋化和黏附功能 ,而是诱导GCB细胞凋亡。结论 IL 2和IL 4联合诱导人GCB细胞CCR3表达 ,CCR3可能具有死亡受体的功能。 相似文献
99.
100.
Jan Petr Jan Kybic Michael Bock Sven Müller Václav Hlavác 《Magnetic resonance in medicine》2007,58(3):582-591
A new reconstruction method for parallel MRI called PROBER is proposed. The method PROBER works in an image domain similar to methods based on Sensitivity Encoding (SENSE). However, unlike SENSE, which first estimates the spatial sensitivity maps, PROBER approximates the reconstruction coefficients directly by B-splines. Also, B-spline coefficients are estimated at once in order to minimize the reconstruction error instead of estimating the reconstruction in each pixel independently (as in SENSE). This makes the method robust to noise in reference images. No presmoothing of reference images is necessary. The number of estimated parameters is reduced, which speeds up the estimation process. PROBER was tested on simulated, phantom, and in vivo data. The results are compared with commercial implementations of the algorithms SENSE and GRAPPA (Generalized Autocalibrating Partially Parallel Acquisitions) in terms of elapsed time and reconstruction quality. The experiments showed that PROBER is faster than GRAPPA and SENSE for images wider than 150x150 pixels for comparable reconstruction quality. With more basis functions, PROBER outperforms both SENSE and GRAPPA in reconstruction quality at the cost of slightly increased computational time. 相似文献